Cookies

Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

May 2019 Issue of The Cannabis Scientist

This month we explore the pharmaceutical industry's increasing interest in cannabis-derived medicines, and the unique challenges posed by translating cannabinoids into prescription drugs. Plus, we cover the latest hot topics in the field – synthetic cannabinoids, mental health effects and the need for rigorous testing – and sit down with Reggie Gaudino to discuss his journey to becoming a guru of cannabis genetics and intellectual property.

Register to download

Register here to download any issue of The Cannabis Scientist for FREE.

Login

Forgot your password?

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

 Business & Profession Business

Under Attack

| Rich Whitworth

The cannabis universe is evolving rapidly, but how will newcomers shape the field?
Research & Development Neurology & psychology

Fishing for Answers

| Matthew Hallam

Cannabinoid receptor 2 exerts behavioural effects in zebrafish - and may do in humans, too.
Research & Development Adverse effects

I Wanna Be Sedated

| Matthew Hallam

Does cannabis counteract medical sedation?
Research & Development Adverse effects

Cannabis on the Brain

| Matthew Hallam

Does cannabis use impact long-term mental health? New research suggests that it just might.

Research & Development Medical research

Dawn of the (Synthetic) Dope

| Matthew Hallam

Synthetic cannabinoids have become ubiquitous, but how do they exert their 'zombifying' effects?
Business & Profession Business

In the News...

| Matthew Hallam

Get up to speed on some of the latest cannabis content hitting headlines.
Business & Profession Pesticide analysis

Time for Testing

| Sponsored by Waters

Cannabis testing: regulation, evolution and the need for nuanced debate.
Research & Development Pharmaceutical

Pharma Takeover: Under Construction?

| James Strachan

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?
Testing & Processing Omics

The Genetics – and IP – Guru

| Reggie Gaudino

Sitting Down With… Reggie Gaudino, President, Director of R&D, and Director of Intellectual Property, Steep Hill Labs, Berkeley, California, USA.

Other issues of 2019